Partnering

Inova Top 10 Newsletter – September 2017

It was a historical month in the field of immuno-oncology and the biopharma industry in general. Last month, we’ve seen back-to-back news about CAR-T therapy, from Gilead Science’s $ 11.9 Billion acquisition of Kite Pharma to the approval of the first CAR-T therapy in the world from Novartis. Meanwhile, we have seen several articles […]

By |September 12th, 2017|Uncategorized|0 Comments

Improving Drug Discovery through Partnerships

By |January 7th, 2015|Uncategorized|Comments Off on Improving Drug Discovery through Partnerships

How Did NPS Pharma Survive and Thrive in Turbulent Times? Partnering.

By |November 6th, 2014|Uncategorized|Comments Off on How Did NPS Pharma Survive and Thrive in Turbulent Times? Partnering.

How Partnering Pays Off: Leveraging External Assets to Boost Pipeline Value

By |July 31st, 2014|Uncategorized|Comments Off on How Partnering Pays Off: Leveraging External Assets to Boost Pipeline Value

Open Innovation in Pharma: Eli Lilly is showing how it’s done

By |February 5th, 2014|Uncategorized|Comments Off on Open Innovation in Pharma: Eli Lilly is showing how it’s done

Better Partnerships for Better Innovation

By |January 16th, 2014|Uncategorized|Comments Off on Better Partnerships for Better Innovation

Facing high drug R&D costs? Partnering can help

By |August 19th, 2013|Uncategorized|Comments Off on Facing high drug R&D costs? Partnering can help

Collaboration for Innovation: The Oil Sands

By |August 6th, 2013|Uncategorized|1 Comment

Finding Success in Emerging Markets with Flexible Partnering

By |July 8th, 2013|Uncategorized|Comments Off on Finding Success in Emerging Markets with Flexible Partnering

Portals for Partnering: Harvesting Greater Value from Partnering Activities

By |June 25th, 2013|Uncategorized|Comments Off on Portals for Partnering: Harvesting Greater Value from Partnering Activities